Central bone marrow histopathology and JAK2V617F analysis in 235 study patients
. | N . | % . | JAK2 positive (n) . | JAK2 allele burden Median (%) . | JAK2 negative (n) . |
---|---|---|---|---|---|
ET | 194 | 82.5 | 79 | 8.7 | 73 |
PMF-0 (fiber grade 0) | 16 | 6.8 | 10 | 11.7** | 3 |
PMF-1 (fiber grade 1) | 3 | 1.3 | 1 | — | 0 |
PV (PV-like pattern) | 16 | 6.8 | 8 | 10.4 | 5 |
–Unclassifiable | 6 | 2.6 | 9* | — | 11* |
. | N . | % . | JAK2 positive (n) . | JAK2 allele burden Median (%) . | JAK2 negative (n) . |
---|---|---|---|---|---|
ET | 194 | 82.5 | 79 | 8.7 | 73 |
PMF-0 (fiber grade 0) | 16 | 6.8 | 10 | 11.7** | 3 |
PMF-1 (fiber grade 1) | 3 | 1.3 | 1 | — | 0 |
PV (PV-like pattern) | 16 | 6.8 | 8 | 10.4 | 5 |
–Unclassifiable | 6 | 2.6 | 9* | — | 11* |